Measuring the dose in bone for spine stereotactic body radiotherapy

Design and validation of a novel dosimetry phantom for motion management audits

BACKGROUND

We present a novel phantom design for conducting end-to-end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion-included) and the dose delivered to the time-averaged motion of the phantom (motion-excluded) to be conducted simultaneously.

PURPOSE

To demonstrate the phantom's utility in a dosimetry audit and capacity to detect errors by quantifying spatial and dosimetric reproducibility.

METHODS

Spatial and dosimetric reproducibility was quantified by repeat exposures using a simple lateral beam. Five exposures per measurement configuration were used. In each series of five measurements, the median film was used as the series reference to quantify the reproducibility of the remaining "test films." Spatial reproducibility was quantified by comparing the position of isodose lines in two axes on the test films back to the series reference. Dosimetric reproducibility was quantified using gamma comparison between each test film and the series reference. Proof-of-concept of the motion-excluded measurement capability was also established by comparing all films to treatment planning system (TPS) calculated dose distributions.

RESULTS

Spatial reproducibility was better than 1 mm on all assessed metrics across all measurements. Film-to-film local gamma passing rates at 3%/0.6 mm were above 90% for all measurements. Film-to-TPS global gamma passing rates at 3%/1 mm were >95% in the motion-excluded measurement series', but <80% in the motion-included series, highlighting the utility of the motion-excluded measurements.

CONCLUSIONS

Measurements were highly reproducible and of sufficient accuracy/reproducibility to facilitate multiple avenues of analysis in a prospective dosimetry audit. Motion-excluded measurements were directly comparable to the TPS dose distribution. Motion-included measurements may yield more clinically-relevant information about the actual dose administered to the target. This promises greater sensitivity to motion management-related errors, detectable in the setting of a dosimetry audit for motion management.

Commissioning small fields in lung using Monte Carlo corrected film measurements

PURPOSE

Current commissioning of radiotherapy treatment planning systems with heterogeneous phantoms generally measures the dose delivered in solid water downstream of the lung material. The dose delivered directly in lung material is important to characterise the uncertainty of lung stereotactic body radiotherapy (SBRT) treatments, but film measurements require a correction to accurately measure dose to lung.

METHODS

Monte Carlo (MC) modelled corrections were applied to film measurements used for commissioning of lung SBRT. Medium dependent correction factors, kmed, were established using 6 and 10 MV simulations to account for film being calibrated in water but measuring in regions of lung material. The correction factors are dependent on energy, field size, and position. To avoid the onerous requirement of modelling each individual beam to correctly match penumbra an alternative approach is presented where the correction is applied as a function of isodose level for a nominal field size.

RESULTS

Improvement in central axis dose agreements was seen for all field sizes, with the largest improvement of 7 % observed for 6MV 1 × 1 cm2 field. Application of position dependent corrections improved the percentage of points passing a 5 %/1 mm or 3 %/1 mm gamma assessment in all cases, whilst a uniform central axis correction did not improve the passing rate in most cases.

CONCLUSIONS

MC simulations provide a method for correcting dose measured in lung materials allowing more accurate comparison with treatment planning system doses. In this work a generic approach to correct small field film lung measurements as a function of isodose levels is presented.

Assessment of four dose calculation algorithms using IAEA-TECDOC-1583 with medium dependency correction factor (Kmed) application

PURPOSE

This study discusses the measurement of dose in clinical commissioning tests described in IAEA-TECDOC-1583. It explores the application of Monte Carlo (MC) modelled medium dependency correction factors (Kmed) for accurate dose measurement in bone and lung materials using the CIRS phantom.

METHODS

BEAMnrc codes simulate radiation sources and model radiation transport for 6 MV and 15 MV photon beams. CT images of the CIRS phantom are converted to an MC compatible phantom. The PTW 30013 farmer chamber measures doses within modeled CIRS phantom. Kmed are determined by averaging values from four central voxels within the sensitive volume of the farmer chamber. Kmed is calculated for Dm.m and Dw.w algorithm types in bone and lung media for both photon beams.

RESULTS

Average modelled correction factors for Dm.m calculations using the farmer chamber are 0.976 (±0.1 %) for 6 MV and 0.979 (±0.1 %) for 15 MV in bone media. Correspondingly, correction factors for Dw.w calculations are 0.99 (±0.3 %) and 0.992 (±0.4 %), respectively. For lung media, average correction factors for Dm.m calculations are 1.02 (±0.3 %) for 6 MV and 1.022 (±0.4 %) for 15 MV. Correspondingly, correction factors for Dw.w calculations are 1.01 (±0.3 %) and 1.012 (±0.2 %), respectively.

CONCLUSIONS

This study highlights the significant impact of applying Kmed on dose differences between measurement and calculation during the dose audit process.

Experimental validation of absorbed dose-to-medium calculation algorithms in heterogeneous media

Objective.The aim of this work was to determine heterogeneous correction factorshQclin,Qreffclin,frefdetm,wto validate absorbed dose-to-mediumDm,Qclinm,fclincalculation algorithms from detector readings. The impact of detector orientation perpendicular and parallel to the beam central axis on the correction factors was also investigated.Approach.ThehQclin,Qreffclin,frefdetm,wfactors were calculated for four types of detectors (PTW PinPoint T31016, PTW microDiamond T60019, PTW microSilicon T60023 and EBT3 film) placed in different media (cortical bone, lung, adipose tissue, Teflon and RW3) for the 6 MV energy beam with a 10 × 10 cm2field size. These corrections were then applied to the detector measurements performed at different depths in heterogeneous phantoms.Main results.ThehQclin,Qreffclin,frefdetm,wfactors mainly depended on the media and slightly on the type of detector. Considering all detectors, the largest corrections were found in high-density media with values ranging from 0.911 to 0.934 in cortical bone. For comparison, the corrections in other media were closer to unity with values from 0.966 (lung and RW3) to 0.991 (adipose tissue). Except for the PinPoint T31016, detector orientation-dependence was observed especially in high-density media. A good agreement (≤1.5%) was found betweenDm,Qclinm,fclincalculations and the detector readings corrected with thehQclin,Qreffclin,frefdetm,wfactor for all studied heterogeneous phantoms.Significance.This paper could serve as an initial guideline for medical physicists involved in the validation of the advanced type-b dose calculation algorithms reportingDm,Qclinm,fclin. To our knowledge, this is the first study to assess the impact of the orientation of different detectors in heterogeneous media. The orientation dependence of the detector response observed in water may not reflect what is observed in heterogeneous media, especially in high-density media. The knowledge of thehQclin,Qreffclin,frefdetm,wfactors becomes mandatory for accurate interpretation of detector readings and comparisons withDm,Qclinm,fclincalculations.

Dosimetric verification of four dose calculation algorithms for spine stereotactic body radiotherapy

The applications of Type B [anisotropic analytical algorithm (AAA) and collapsed cone (CC)] and Type C [Acuros XB (AXB) and photon Monte Carlo (PMC)] dose calculation algorithms in spine stereotactic body radiotherapy (SBRT) were evaluated. Water- and bone-equivalent phantoms were combined to evaluate the percentage depth dose and dose profile. Subsequently, 48 consecutive patients with clinical spine SBRT plans were evaluated. All treatment plans were created using AXB in Eclipse. The prescription dose was 24 Gy in two fractions at a 10 MV FFF on TrueBeam. The doses were then recalculated with AAA, CC and PMC while maintaining the AXB-calculated monitor units and beam arrangement. The dose index values obtained using the four dose calculation algorithms were then compared. The AXB and PMC dose distributions agreed with the bone-equivalent phantom measurements (within ±2.0%); the AAA and CC values were higher than those in the bone-equivalent phantom region. For the spine SBRT plans, PMC, AAA and CC were overestimated compared with AXB in terms of the near minimum and maximum doses of the target and organ at risk, respectively; the mean dose difference was within 4.2%, which is equivalent with within 1 Gy. The phantom study showed that the results from AXB and PMC agreed with the measurements within ±2.0%. However, the mean dose difference ranged from 0.5 to 1 Gy in the spine SBRT planning study when the dose calculation algorithms changed. Users should incorporate a clinical introduction that includes an awareness of these differences.

Commissioning of Aktina SRS cones and dosimetric validation of the RayStation photon Monte Carlo dose calculation algorithm

Clinical implementation of SRS cones demands particular experimental care and dosimetric considerations in order to deliver precise and safe radiotherapy to patients. The purpose of this work was to present the commissioning data of recent Aktina cones combined with a 6MV flattened beam produced by an Elekta VersaHD linear accelerator. Additionally, the modelling process, and an assessment of dosimetric accuracy of the RayStation Monte Carlo dose calculation algorithm for cone based SRS was performed. There are currently no studies presenting beam data for this equipment and none that outlines the modelling parameters and validation of dose calculation using RayStation's photon Monte Carlo dose engine with cones. Beam data was measured using an SFD and a microDiamond and benchmarked against EBT3 film for cones of diameter 5-39 mm. Modelling was completed and validated within homogeneous and heterogeneous phantoms. End-to-end image-guided validation was performed using a StereoPHAN™ housing, an SRS MapCHECK and EBT3 film, and calculation time was investigated as a function of statistical uncertainty and field diameter. The TPS calculations agreed with measured data within their estimated uncertainties and clinical treatment plans could be calculated in under a minute. The data presented serves as a reference for others commissioning Aktina stereotactic cones and the modelling parameters serve similarly, while providing a starting point for those commissioning the same TPS algorithm for use with cones. It has been shown in this work that RayStation's Monte Carlo photon dose algorithm performs satisfactorily in the presence of SRS cones.

Measuring dose in lung identifies peripheral tumour dose inaccuracy in SBRT audit

PURPOSE

Stereotactic Body Radiotherapy (SBRT) for lung tumours has become a mainstay of clinical practice worldwide. Measurements in anthropomorphic phantoms enable verification of patient dose in clinically realistic scenarios. Correction factors for reporting dose to the tissue equivalent materials in a lung phantom are presented in the context of a national dosimetry audit for SBRT. Analysis of dosimetry audit results is performed showing inaccuracies of common dose calculation algorithms in soft tissue lung target, inhale lung material and at tissue interfaces.

METHODS

Monte Carlo based simulation of correction factors for detectors in non-water tissue was performed for the soft tissue lung target and inhale lung materials of a modified CIRS SBRT thorax phantom. The corrections were determined for Gafchromic EBT3 Film and PTW 60019 microDiamond detectors used for measurements of 168 SBRT lung plans in an end-to-end dosimetry audit. Corrections were derived for dose to medium (Dm,m) and dose to water (Dw,w) scenarios.

RESULTS

Correction factors were up to -3.4% and 9.2% for in field and out of field lung respectively. Overall, application of the correction factors improved the measurement-to-plan dose discrepancy. For the soft tissue lung target, agreement between planned and measured dose was within average of 3% for both film and microDiamond measurements.

CONCLUSIONS

The correction factors developed for this work are provided for clinical users to apply to commissioning measurements using a commercially available thorax phantom where inhomogeneity is present. The end-to-end dosimetry audit demonstrates dose calculation algorithms can underestimate dose at lung tumour/lung tissue interfaces by an average of 2-5%.

A survey of compliance with stereotactic ablative body radiotherapy quality recommendations

INTRODUCTION

Many publications have proposed quality standards for stereotactic ablative body radiotherapy (SABR). However, data on the level of compliance with these guidelines is lacking in the literature. This study aimed to understand how these guidelines are applied in the clinic and to identify barriers to implementing such recommendations.

METHODS

Interviews were conducted with multidisciplinary staff at radiation oncology centres across New South Wales formulated around the RANZCR Guidelines for Safe Practice of Stereotactic Body (Ablative) Radiation Therapy. The interview responses were grouped into 20 topics, assessed against the guidelines and thematically analysed.

RESULTS

Good compliance with the guidelines was found, with more than 80% of centres achieving satisfactory results in more than half the topics. The areas with the lowest compliance were auditing, risk assessment and reporting recommendations. Barriers to the quality of SABR treatments included limited training opportunities, low patient numbers and a lack of clear requirements on comprehensive auditing and reporting.

CONCLUSION

Overall, the centres surveyed reported good compliance with most of the RANZCR SABR guidelines. The tasks with the lowest compliance were those that monitor quality outcomes. Potential strategies for improvement include inclusion in clinical trials and the use of databases which link treatment parameters, dosimetry and outcomes. Further work will focus on the barriers identified in this survey and propose practical solutions to improve compliance in these areas.

Calorimeter measurements of absolute dose in aluminum, a surrogate of bone, to validate dose-to-medium in Acuros XB

Objective. While the accuracy of dose calculations in water with Acuros XB is well established, experimental validation of dose in bone is limited. Acuros XB reports both dose-to-medium and dose-to-water, and these values differ in bone, but there are no reports of measurements of validation in bone. This work compares Acuros XB calculations to measurements of absolute dose in aluminum (medium similar to bone). The validity of using selected relative dosimeters in aluminum is also investigated.Approach. A calorimeter with an aluminum core embedded in an aluminum phantom was selected as bone surrogate for the measurement of absolute dose. Matching the medium of the core to the medium of the phantom allowed eliminating the calculation of the conversion between media. The dose was measured at the fixed depth of 3.3 cm in aluminum (∼9 g·cm^-2) with 6X, 10X, 6FFF and 10FFF photon beams from a TrueBeam Varian linac. In addition, experimental cross-calibration between water and aluminum was performed for an IBA CC13 ionization chamber, a PTW microDiamond and EBT3 Gafchromic film.Main results. Calculations with Acuros XB dose-to-medium in aluminum differed from the calorimetry data by -2.8% to -3.5%, depending on the beam. Use of dose-to-water would have resulted in about 39% discrepancy. The cross calibration coefficient between water and aluminum yielded values of about 0.87 for the CC13 chamber, 0.91 for the microDiamond, and 0.88 for the film, and independent of the beam within about ±1%.Significance. It was demonstrated the value of the dose-to-medium in aluminum (surrogate of bone) computed with Acuros XB is close to the value of the absolute dose measured with a calorimeter, and there is a significant discrepancy when dose-to-water is used instead. The use of an ionization chamber, a microDiamond and Gafchromic film in aluminum required a considerable correction from calibration in water.

Dose calculation and reporting with a linear Boltzman transport equation solver in vertebral SABR

Vertebral Stereotactic ablative body radiotherapy (SABR) involves substantial tumour density heterogeneities. We evaluated the impact of a linear Boltzmann transport equation (LBTE) solver dose calculation on vertebral SABR dose distributions. A sequential cohort of 20 patients with vertebral metastases treated with SABR were selected. Treatment plans were initially planned with a convolution style dose calculation algorithm. The plan was copied and recalculated with a LBTE algorithm reporting both dose to water (D_w) or dose to medium (D_m). Target dose as a function of CT number, and spinal cord dose was compared between algorithms. Compared with a convolution algorithm, there was minimal change in PTV D90% with LBTE. LBTE reporting D_m resulted in reduced GTV D50% by (mean, 95% CI) 2.2% (1.9-2.6%) and reduced Spinal Cord PRV near-maximum dose by 3.0% (2.0-4.1%). LBTE reporting D_w resulted in increased GTV D50% by 2.4% (1.8-3.0%). GTV D50% decreased or increased with increasing CT number with D_m or D_w respectively. LBTE, reporting either D_m or D_w resulted in decreased central spinal cord dose by 8.7% (7.1-10.2%) and 7.2% (5.7-8.8%) respectively. Reported vertebral SABR tumour dose when calculating with an LBTE algorithm depends on tumour density. Spinal cord near-maximum dose was lower when using LBTE algorithm reporting D_m, which may result in higher spinal cord doses being delivered than with a convolution style algorithm. Spinal cord central dose was significantly lower with LBTE, potentially reflecting LBTE transport approximations.